Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03911453
Title Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Arizona
Indications

triple-receptor negative breast cancer

Therapies

Rucaparib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Arizona Cancer Center Recruiting Tucson Arizona 85724 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field